去年，雅培表现最佳的业务板块Diabetes Care实现营收8.00B美元。United States的营收贡献最高，去年达到17.13B美元。最近一个季度，截至2026-06-30，雅培表现最佳的业务板块Diabetes Care实现营收2.19B美元。All other Countries的营收贡献最高，达到7.38B美元。

业务

营业收入

占比

年报

年报

单季报

Diabetes Care

Core Laboratory

Adult Nutritionals

Key Emerging Markets

Pediatric Nutritionals

Vascular

Electrophysiology

Rhythm Management

Structural Heart

Rapid Diagnostics

Heart Failure

Other

Neuromodulation

Point of Care

Molecular

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Diabetes Care

8.00B(18.04%)

6.80B(16.22%)

5.76B(14.36%)

4.76B(10.90%)

4.33B(10.05%)

3.27B(9.44%)

Core Laboratory

5.36B(12.09%)

5.24B(12.48%)

5.16B(12.86%)

4.89B(11.20%)

5.13B(11.90%)

4.47B(12.93%)

Adult Nutritionals

4.48B(10.10%)

4.39B(10.46%)

4.22B(10.52%)

3.98B(9.11%)

4.00B(9.28%)

3.52B(10.17%)

Key Emerging Markets

4.17B(9.40%)

3.86B(9.20%)

3.81B(9.49%)

3.73B(8.54%)

3.54B(8.22%)

3.21B(9.27%)

Pediatric Nutritionals

3.97B(8.96%)

4.02B(9.59%)

3.93B(9.81%)

3.48B(7.97%)

4.30B(9.98%)

4.13B(11.92%)

Vascular

3.00B(6.76%)

2.84B(6.76%)

2.68B(6.68%)

2.48B(5.69%)

2.65B(6.16%)

2.34B(6.76%)

Electrophysiology

2.76B(6.24%)

2.47B(5.88%)

2.19B(5.47%)

1.93B(4.41%)

1.91B(4.43%)

1.58B(4.56%)

Rhythm Management

2.65B(5.98%)

2.39B(5.70%)

2.25B(5.62%)

2.12B(4.85%)

2.20B(5.10%)

1.91B(5.53%)

Structural Heart

2.52B(5.69%)

2.25B(5.35%)

1.94B(4.85%)

1.71B(3.92%)

1.61B(3.74%)

1.25B(3.60%)

Rapid Diagnostics

2.45B(5.54%)

3.00B(7.14%)

3.69B(9.20%)

10.18B(23.31%)

8.55B(19.86%)

4.38B(12.64%)

Heart Failure

1.45B(3.27%)

1.28B(3.05%)

1.16B(2.89%)

920.00M(2.11%)

889.00M(2.06%)

740.00M(2.14%)

Other

1.39B(3.13%)

1.35B(3.22%)

1.27B(3.17%)

1.20B(2.74%)

1.23B(2.86%)

1.16B(3.35%)

Neuromodulation

1.01B(2.28%)

962.00M(2.29%)

890.00M(2.22%)

770.00M(1.76%)

781.00M(1.81%)

702.00M(2.03%)

Point of Care

606.00M(1.37%)

588.00M(1.40%)

565.00M(1.41%)

525.00M(1.20%)

536.00M(1.24%)

516.00M(1.49%)

Molecular

517.00M(1.17%)

521.00M(1.24%)

574.00M(1.43%)

995.00M(2.28%)

1.43B(3.31%)

1.44B(4.16%)

地区

营业收入

占比

年报

年报

单季报

United States

All other Countries

Germany

China

India

Switzerland

Japan

United Kingdom

India

The Netherlands

Canada

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

17.13B(38.63%)

16.32B(38.91%)

15.45B(38.53%)

18.14B(41.56%)

16.64B(38.63%)

13.02B(37.63%)

11.40B(35.73%)

All other Countries

15.98B(36.05%)

14.85B(35.39%)

14.08B(35.11%)

14.84B(34.00%)

15.52B(36.02%)

12.58B(36.35%)

11.53B(36.15%)

Germany

2.76B(6.22%)

2.54B(6.05%)

2.35B(5.85%)

2.34B(5.36%)

2.57B(5.97%)

2.11B(6.09%)

1.75B(5.49%)

China

1.91B(4.30%)

2.11B(5.04%)

2.25B(5.62%)

2.13B(4.89%)

2.39B(5.55%)

1.97B(5.68%)

2.35B(7.35%)

India

1.87B(4.22%)

--(--)

Switzerland

1.87B(4.22%)

1.75B(4.16%)

1.64B(4.08%)

1.34B(3.06%)

1.31B(3.05%)

1.14B(3.29%)

1.07B(3.35%)

Japan

1.48B(3.33%)

1.44B(3.44%)

1.51B(3.77%)

1.93B(4.43%)

1.70B(3.93%)

1.39B(4.00%)

1.44B(4.50%)

United Kingdom

1.34B(3.02%)

--(--)

India

--(--)

1.82B(4.33%)

1.75B(4.36%)

1.65B(3.78%)

1.56B(3.62%)

1.32B(3.82%)

1.40B(4.38%)

The Netherlands

--(--)

1.12B(2.68%)

1.07B(2.68%)

--(--)

1.08B(3.13%)

975.00M(3.06%)

Canada

--(--)

1.28B(2.93%)

1.39B(3.22%)

--(--)